In particular, three major subsets are recognized including classical (CD14+CD16−), intermediate (CD14+/− CD16low), and non-classical monocytes (CD14−CD16+), and the latter subset is considered to harbor a tumor-promoting phenotype [212]. Here, CD14 is linked to neoplasm.